Skip to main content
Header image
User picture
Phone: +420 585632144
Groups: IMTM, LIG, STAFF, SUPERVISOR

About me

Junior researcher in cellular biology and translational medicine, with ample experience in conducting and managing independent scientific projects. I am actively developing my own research program focused on the cellular response to proteotoxic stress and new techniques. 

Author of 16 original scientific publications with over 1000 SCI citations. H-index 11

Journals

MAJERA, D., Z. ŠKROTT, J. BOUCHAL, J. BARTKOVA, D. ŠIMKOVÁ, M. GACHECHILADZE, J. STEIGEROVÁ, D. KURFÜRSTOVÁ, J. GURSKÝ, G. KOŘÍNKOVÁ, K. CWIERTKA, Z. HODNY, M. MISTRÍK, J. BÁRTEK
Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram. The Prostate. 2018, 79(4), 352-362, ISSN: 0270-4137, PMID: 30499118,
ŠKROTT, Z., M. MISTRÍK, K. ANDERSEN, S. FRIIS, D. MAJERA, J. GURSKÝ, T. OŽDIAN, J. BARTKOVA, Z. TURI, P. MOUDRÝ, M. KRAUS, M. MEDVEDÍKOVÁ, J. VÁCLAVKOVÁ, P. DŽUBÁK, I. VROBEL, P. POUCKOVA, J. SEDLACEK, A. MIKLOVICOVA, A. KUTT, J. MATTOVA, C. DRIESSEN, Q. DOU, J. OLSEN, M. HAJDÚCH, B. CVEK, R. DESHAIES, J. BÁRTEK
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017, 552(7684), 194-199, ISSN: 0028-0836, PMID: 29211715,
CHROMÁ, K., M. MISTRÍK, P. MOUDRÝ, J. GURSKÝ, M. LIPTAY, R. STRAUSS, Z. ŠKROTT, R. VRTEL, J. BARTKOVA, J. KRAMARA, J. BÁRTEK
Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress. Oncogene. 2017, 36(17), 2405-2422, ISSN: 0950-9232, PMID: 27841863,

Open positions

1 Molecular and Translational Medicine
Project: Cellular stress in health and disease
Supervisors: Mistrík Martin Ph.D., Moudrý Pavel Ph.D., Škrott Zdeněk Ph.D.
Available: 3
Intended for: Doctoral training